Evidence map›Paper›PMID 35495416›Full record

ArticleJournal of aerosol science2022

Detection of SARS-CoV-2 in the air in Indian hospitals and houses of COVID-19 patients.

Shivranjani C Moharir, Sharath Chandra Thota, Arushi Goel, Bhuwaneshwar Thakur, Dixit Tandel, S Mahesh Reddy, Amareshwar Vodapalli, Gurpreet Singh Bhalla, Dinesh Kumar, Digvijay Singh Naruka and 11 more

Open access · greenAbstract read
In one paragraph

Article in Journal of aerosol science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Shivranjani C MoharirCSIR- Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, 500007, India.
Sharath Chandra ThotaCSIR- Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, 500007, India.
Arushi GoelCSIR- Institute of Microbial Technology (CSIR-IMTech), Chandigarh, 160036, India.
Bhuwaneshwar ThakurCSIR- Institute of Microbial Technology (CSIR-IMTech), Chandigarh, 160036, India.
Dixit TandelCSIR- Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, 500007, India.
S Mahesh ReddyCSIR- Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, 500007, India.
Amareshwar VodapalliCSIR- Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, 500007, India.
Gurpreet Singh BhallaCSIR- Institute of Microbial Technology (CSIR-IMTech), Chandigarh, 160036, India.
Dinesh KumarCSIR- Institute of Microbial Technology (CSIR-IMTech), Chandigarh, 160036, India.
Digvijay Singh NarukaCSIR- Institute of Microbial Technology (CSIR-IMTech), Chandigarh, 160036, India.
Ashwani KumarCSIR- Institute of Microbial Technology (CSIR-IMTech), Chandigarh, 160036, India.
Amit TuliCSIR- Institute of Microbial Technology (CSIR-IMTech), Chandigarh, 160036, India.
Swathi SuravaramESI Hospital and Medical College, Hyderabad, 500018, India.
Thrilok Chander BingiCOVID-19 Nodal Centre, Hyderabad, 500025, India.
M SrinivasESI Hospital and Medical College, Hyderabad, 500018, India.
Rajarao MesipoguCOVID-19 Nodal Centre, Hyderabad, 500025, India.
Krishna ReddyDurgabai Deshmukh Hospital, Hyderabad, 500044, India.
Sanjeev KhoslaCSIR- Institute of Microbial Technology (CSIR-IMTech), Chandigarh, 160036, India.
Krishnan H HarshanCSIR- Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, 500007, India.
Karthik Bharadwaj TallapakaCSIR- Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, 500007, India.
Rakesh K MishraCSIR- Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, 500007, India.
Centre for Cellular and Molecular Biology · INInstitute of Microbial Technology · INESIC Hospital · INNonFerrous Materials Technology Development Centre · INDurgabai Deshmukh Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To understand the transmission characteristics of severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) through air, samples from different locations occupied by coronavirus disease (COVID-19) patients were analyzed. Three sampling strategies were used to understand the presence of virus in the air in different environmental conditions. In the first strategy, which involved hospital settings, air samples were collected from several areas of hospitals like COVID-intensive-care units (ICUs), nurse-stations, COVID-wards, corridors, non-COVID-wards, personal protective equipment (PPE) doffing areas, COVID rooms, out-patient (OP) corridors, mortuary, COVID casualty areas, non-COVID ICUs and doctors' rooms. Out of the 80 air samples collected from 6 hospitals from two Indian cities- Hyderabad and Mohali, 30 samples showed the presence of SARS-CoV-2 nucleic acids. In the second sampling strategy, that involved indoor settings, one or more COVID-19 patients were asked to spend a short duration of time in a closed room. Out of 17 samples, 5 samples, including 4 samples collected after the departure of three symptomatic patients from the room, showed the presence of SARS-CoV-2 nucleic acids. In the third strategy, involving indoor settings, air samples were collected from rooms of houses of home-quarantined COVID-19 patients and it was observed that SARS-CoV-2 RNA could be detected in the air in the rooms occupied by COVID-19 patients but not in the other rooms of the houses. Taken together, we observed that the air around COVID-19 patients frequently showed the presence of SARS-CoV-2 RNA in both hospital and indoor residential settings and the positivity rate was higher when 2 or more COVID-19 patients occupied the room. In hospitals, SARS-CoV-2 RNA could be detected in ICUs as well as in non-ICUs, suggesting that the viral shedding happened irrespective of the severity of the infection. This study provides evidence for the viability of SARS-CoV-2 and its long-range transport through the air. Thus, airborne transmission could be a major mode of transmission for SARS-CoV-2 and appropriate precautions need to be followed to prevent the spread of infection through the air.

Indexed as

Airborne transmissionClosed-room airCoronavirusCOVID-19Hospital airSARS-CoV-2SARS-CoV-2 infection

Identifiers

PMID35495416
PMCPMC9040488
OpenAlexW4224882692

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.